MANDY ERWIN: Open Payments
NPI 1760420244 · DENHAM SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 38 payments from 14 companies in 2025. Trend: 2023 $1,080 · 2024 $940 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $267 |
| AstraZeneca Pharmaceuticals LP | 4 | $217 |
| Lilly USA, LLC | 4 | $78 |
| Antares Pharma, Inc. | 3 | $68 |
| Novo Nordisk Inc | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| ABBVIE INC. | 3 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $22 |
Products named: Auvelity, BREZTRI, AIRSUPRA, XYOSTED, MOUNJARO, REXULTI, VOQUEZNA, Rybelsus.
Industry payments across LA — which companies pay providers there.
